Considering the PD-L1-mediated inhibition of effector T cells, it was hypothesized that PD-L1-positive tumors downregulate anti-tumor cytotoxic defenses of immune cells, particularly cyTCs [40]. The gene discussed is CD274; the disease is neoplasm.